On this page
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
The MCCC1 gene provides instructions for a key enzyme involved in the breakdown of amino acids, and variants are associated with 3-methylcrotonyl-CoA carboxylase deficiency. The MCCC1 gene is crucial for cellular metabolism, coding for a subunit of the 3-methylcrotonyl-CoA carboxylase enzyme.
MCCC1 is located on the long (q) arm of chromosome 3, at band 3q27.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 3 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MCCC1 gene, also known as methylcrotonyl-CoA carboxylase subunit 1, is essential for normal metabolic function within the human body. It provides the genetic blueprint for a component of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme, which is responsible for specific steps in the breakdown of proteins.
Disruptions to the MCCC1 gene can impair the body's ability to process certain amino acids, leading to an inherited metabolic disorder known as 3-methylcrotonyl-CoA carboxylase deficiency. This condition is inherited in an autosomal recessive manner, meaning an individual must inherit two affected copies of the gene to develop the disorder.
What the gene does
The MCCC1 gene directs the production of the alpha subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. This alpha subunit combines with smaller beta subunits, which are produced from the MCCC2 gene, to form a fully functional enzyme complex. Six of these alpha-beta pairings typically assemble to create the complete MCC enzyme.
MCC is located within the mitochondria, the powerhouses of the cell, where it plays a vital role in catabolism - the process of breaking down complex molecules. Specifically, it is involved in the metabolic pathway that breaks down leucine, an essential amino acid obtained from dietary proteins. The MCC enzyme facilitates the conversion of 3-methylcrotonyl-CoA into 3-methylglutaconyl-CoA, which is a critical step in this pathway. Subsequent reactions then convert 3-methylglutaconyl-CoA into molecules that can be used by the cell for energy production.
Video: Genetics 101
Chromosome location
The MCCC1 gene is situated on the long arm of chromosome 3, specifically at position 3q27.1. This location refers to the exact address of the gene within the human genome. The MCCC1 gene comprises instructions for a protein that is 725 amino acids in length.
Protein structure
The MCCC1 protein, which serves as the alpha subunit of the MCC enzyme, contains several distinct functional regions or domains. It features a biotin carboxylation domain, spanning amino acids 48 to 494, which is crucial for binding to the B vitamin biotin - a necessary cofactor for the enzyme's activity. An ATP-grasp domain is located between amino acids 167 and 364, indicating its role in ATP-dependent reactions. Additionally, a biotinyl-binding domain is found towards the C-terminus of the protein, from amino acids 643 to 715, further highlighting its interaction with biotin.
Key variants
Genetic variations, or variants, in the MCCC1 gene can alter the protein's structure or function, potentially leading to health implications. Most identified MCCC1 variants involve changes to single amino acids within the protein. Some variants may also result in a shortened, non-functional version of the MCCC1 protein. The impact of a specific variant often depends on its location within the gene and how it affects the overall structure and activity of the MCC enzyme.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1126del | p.Thr376fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1378-2A>G | - | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1518del | p.Glu506fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1541dup | p.Leu515fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1630del | p.Arg544fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1663_1664dup | p.Lys556fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1679del | p.Asn560fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1731+1del | - | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.1750C>T | p.Gln584Ter | Pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
c.622del | p.Arg208fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 1 deficiency |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants within the MCCC1 gene are associated with an inherited metabolic disorder known as 3-methylcrotonyl-CoA carboxylase deficiency. This condition is characterised by the body's impaired ability to process the amino acid leucine. Individuals affected by this deficiency may experience a range of symptoms, which can vary in severity. The condition is inherited in an autosomal recessive pattern, meaning both copies of the MCCC1 gene must carry a pathogenic variant for an individual to be affected.
Inheritance pattern
Conditions caused by pathogenic MCCC1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The MCCC1 gene is included in several expert-curated panels within the NHS Genomic Medicine Service's PanelApp. It is featured on the DDG2P panel, the Intellectual disability panel, the Likely inborn error of metabolism panel (R98), and the Undiagnosed metabolic disorders panel. Its presence on these panels indicates its recognised clinical significance within the UK healthcare system for diagnosing relevant inherited conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the role of the MCCC1 gene?
The MCCC1 gene provides instructions for the alpha subunit of the 3-methylcrotonyl-CoA carboxylase enzyme. This enzyme is critical for breaking down the amino acid leucine, which is obtained from dietary proteins, within the mitochondria of cells.
What is 3-methylcrotonyl-CoA carboxylase deficiency?
It is an inherited metabolic disorder caused by pathogenic variants in the MCCC1 (or MCCC2) gene. This deficiency impairs the body's ability to properly process certain proteins, specifically the amino acid leucine, which can lead to various health problems.
How is 3-methylcrotonyl-CoA carboxylase deficiency inherited?
This condition follows an autosomal recessive inheritance pattern. This means an individual must inherit two copies of the MCCC1 gene with pathogenic variants (one from each parent) to develop the disorder.
References
- Stadler SC, Polanetz R, Maier EM. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Human mutation. 2006. PMID: 16835865
- Dantas MF, Suormala T, Randolph A. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. Human mutation. 2005. PMID: 16010683
- Desviat LR, Pérez-Cerdá C, Pérez B. Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria. Molecular genetics and metabolism. 2003. PMID: 14680978
- Gallardo ME, Desviat LR, Rodríguez JM. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. American journal of human genetics. 2001. PMID: 11170888
- Baumgartner MR, Almashanu S, Suormala T. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. The Journal of clinical investigation. 2001. PMID: 11181649
- Obata K, Fukuda T, Morishita R. Human biotin-containing subunit of 3-methylcrotonyl-CoA carboxylase gene (MCCA): cDNA sequence, genomic organization, localization to chromosomal band 3q27, and expression. Genomics. 2001. PMID: 11401427
- Holzinger A, Röschinger W, Lagler F. Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency. Human molecular genetics. 2001. PMID: 11406611